(Total Views: 83)
Posted On: 09/09/2025 9:43:31 AM
Post# of 25730
$VRHI VERI MEDTECH (VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock in Open Market Transactions
https://www.otcmarkets.com/stock/VRHI/news/VE...?id=491646
VERI MEDTECH (VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock in Open Market Transactions
NEW YORK, September 9, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: Danny Wilson, Director, completed the additional purchase of 200 shares of VRHI stock at an average price per share of $1.46. With this purchase, Mr. Wilson beneficially owns: 497.626 shares of VRHI stock, including an aggregate of 11,376 shares of VRHI stock purchased by Mr. Wilson via open market transactions to date.
Q2 Key Accomplishments:
$2.86 Million in Revenue
Initiated Audit Process with PCAOB Auditor (in preparation for uplisting)
Relaunched www.VeriMedTech.com
Engaged in Discussions for Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology Companies)
https://www.otcmarkets.com/stock/VRHI/news/VE...?id=491646
VERI MEDTECH (VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock in Open Market Transactions
NEW YORK, September 9, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: Danny Wilson, Director, completed the additional purchase of 200 shares of VRHI stock at an average price per share of $1.46. With this purchase, Mr. Wilson beneficially owns: 497.626 shares of VRHI stock, including an aggregate of 11,376 shares of VRHI stock purchased by Mr. Wilson via open market transactions to date. Q2 Key Accomplishments:
$2.86 Million in Revenue
Initiated Audit Process with PCAOB Auditor (in preparation for uplisting)
Relaunched www.VeriMedTech.com
Engaged in Discussions for Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology Companies)
(0)
(0)
